The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFragrant Prosp. Regulatory News (FPP)

  • This share is currently suspended. It was suspended at a price of 0.516

Share Price Information for Fragrant Prosp. (FPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.516
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.516
FPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Equity Fundraise

1 Mar 2021 07:00

RNS Number : 6104Q
Fragrant Prosperity Holdings Ltd
01 March 2021
 

1st March 2021

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. 

 

Fragrant Prosperity Holdings Limited

("FPP" or the "Company")

Equity Fundraise

Fragrant Prosperity Holdings Limited ("Fragrant" or the "Company") announces it has completed (subject to certain conditions) an equity fundraise of £543,929.61 (gross) (the "Fundraise") through the issue of 10,360,564 ordinary shares (the "Fundraise Shares") at a price of 5.25 pence per ordinary share.

The Fundraise has been undertaken by way of a placing of new ordinary shares ("Placing") of no par value ("Ordinary Shares") in the share capital of the Company and was arranged by Optiva Securities Limited ("Optiva") with its clients. The Fundraise is to provide additional capital for the Company to pursue its investment strategy.

The Fundraise has been undertaken by means of the Placing pursuant to which, the Company will issue 10,360,564 ordinary shares at a price of 5.25p per new ordinary share ("Issue Price"), representing a discount of approximately 12.5% to the closing price of the ordinary shares on 26 February 2021 (being the last practicable dealing date prior to the pricing of this transaction).

Craig J. Marshak, chairman of Fragrant, commented as follows: "this placing provides important additional financing to extend our search and work effort to identify appropriate acquisition candidates, in particular in the burgeoning Cannabis and Cannabis Therapeutics related sectors. In the reasonably near future we expect to identify at least one additional Director who will add to the current in depth experience of the existing board to assist with this search"

Discussions in respect of opportunities that have been presented to the Company are at a very early stage and no agreement has been made with any of the relevant target companies or businesses. Therefore, there is no certainty that any of the current discussions will progress further and/or result in the Company concluding a transaction.

Following Admission of the Fundraising Shares, which is expected to occur at 8.00 am on the 3rd March 2021, the total number of Ordinary Shares in the Company will be 62,223,386. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

*Ends*

 

For more information: http://www.fragrantprosperityholdings.com/

 

Fragrant Prosperity Holdings Limited

Simon Retter/Craig Marshak

+44 (0) 20 3137 1902

Broker: Optiva Securities

Vishal Balasingham +44 (0) 20 3137 1903

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGDGDXRGGDGBB
Date   Source Headline
16th Apr 20214:41 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
16th Apr 20212:05 pmRNSSecond Price Monitoring Extn
16th Apr 20212:00 pmRNSPrice Monitoring Extension
8th Apr 20212:05 pmRNSSecond Price Monitoring Extn
8th Apr 20212:00 pmRNSPrice Monitoring Extension
6th Apr 202111:06 amRNSSecond Price Monitoring Extn
6th Apr 202111:01 amRNSPrice Monitoring Extension
29th Mar 20219:00 amRNSPrice Monitoring Extension
29th Mar 20217:00 amRNSAppointment of Director
17th Mar 20212:05 pmRNSSecond Price Monitoring Extn
17th Mar 20212:00 pmRNSPrice Monitoring Extension
2nd Mar 202111:05 amRNSSecond Price Monitoring Extn
2nd Mar 202111:00 amRNSPrice Monitoring Extension
2nd Mar 20219:05 amRNSSecond Price Monitoring Extn
2nd Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20214:40 pmRNSSecond Price Monitoring Extn
1st Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20219:05 amRNSSecond Price Monitoring Extn
1st Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSEquity Fundraise
26th Feb 20219:06 amRNSSecond Price Monitoring Extn
26th Feb 20219:00 amRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSExpansion of investment mandate
12th Feb 20214:40 pmRNSSecond Price Monitoring Extn
12th Feb 20214:35 pmRNSPrice Monitoring Extension
9th Feb 20214:41 pmRNSSecond Price Monitoring Extn
9th Feb 20214:35 pmRNSPrice Monitoring Extension
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:01 pmRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSHalf-year Report
17th Aug 20207:50 amRNSAnnual Financial Report
8th Jun 20207:50 amRNSConvertible Loan Notes and grant of Options
20th Dec 20197:00 amRNSResult of AGM
16th Dec 20197:00 amRNSIssue of Convertible Loan Notes&Change of Director
25th Nov 20198:34 amRNSHalf-year Report
21st Nov 20197:00 amRNSNotice of AGM
15th Nov 20199:23 amRNSDirectorate Change
12th Nov 20197:00 amRNSAnnual Financial Report
15th Jul 20199:20 amRNSIssue of Equity
17th Jun 20199:07 amRNSIssue of Equity
13th Jun 20199:39 amRNSDirectorate Change
14th Jan 20198:02 amRNSHalf-year Report
1st Oct 20188:57 amRNSResult of AGM
29th Aug 201810:16 amRNSNotice of AGM
21st Aug 20189:57 amRNSFinal Results
15th Aug 20187:20 amRNSHolding(s) in Company
4th Jul 20187:46 amRNSDirectorate Change
28th Mar 201810:52 amRNSDirectorate Change
15th Jan 20181:42 pmRNSHolding(s) in Company - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.